{
  "id": "1f47d046f9c57930",
  "title": "uniQure N . V . Securities Fraud Class Action Result of FDA Approval Delay ... ",
  "description": "20260213T051500Z",
  "content": "",
  "source": "pr-inside.com",
  "source_url": "https://www.pr-inside.com/uniqure-n-v-securities-fraud-class-action-result-of-fda-approval-delay-r5167953.htm",
  "published_at": "20260213T051500Z",
  "fetched_at": "2026-02-14T00:29:18.398832+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pr-inside.com/uniqure-n-v-securities-fraud-class-action-result-of-fda-approval-delay-r5167953.htm",
    "url_mobile": "",
    "title": "uniQure N . V . Securities Fraud Class Action Result of FDA Approval Delay ... ",
    "seendate": "20260213T051500Z",
    "socialimage": "",
    "domain": "pr-inside.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}